Clonal Lymphocyte Expansions and JAK-STAT Pathway Mutations Define a Pathogenic Continuum Driving Resistance to Gluten-Free Diet in Celiac Disease
Georgia Malamut(Délégation Paris 5), Anaïs Levescot(Inserm), Chantal Brouzes, Frédéric Beuvon(Université Paris Cité), Véred Abitbol(Hôpital Cochin), Cécile Masson(Délégation Paris 5), Vahid Asnafi(Hôpital Necker-Enfants Malades), Olivier Hermine(Centre National de la Recherche Scientifique), Benoît Terris(Unknown), Guillaume Bouguen(Inserm), Ludovic Lhermitte(Hôpital Necker-Enfants Malades), Mathurin Fuméry(Centre Hospitalier Universitaire Amiens-Picardie), Barbara Burroni(Hôpital Cochin), Nicolas Guégan(Délégation Paris 5), Henri Duboc(Hôpital Louis-Mourier), David Sibon(Hôpital Necker-Enfants Malades), Romain Coriat(Hôpital Cochin), Francesco Carbone(Inserm), Mathieu Uzzan, Isabelle Nion–Larmurier(Sorbonne Université), Christine Bole(Centre National de la Recherche Scientifique), Marine Luka(Inserm), Nadine Cerf–Bensussan(Université Paris Cité), Mickaël Ménager(Inserm), Sascha Cording(Inserm)
Cited by 0
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
|The Journal of Experimental Medicine|2011|797
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
|JAMA Internal Medicine|2020|777